The Biotechnology Practice Group at Andrus serves biotechnology, pharmaceutical and chemical industries including medical, agricultural, horticultural, veterinary, food processing, and green technologies. We meet the diverse needs of established companies, start-ups, research institutions and universities.

Our attorneys have extensive experience acquiring and enforcing patent rights worldwide, negotiating licenses and technology transfers, and evaluating all aspects of proprietary technology such as performing due diligence, patent validity, infringement, and freedom-to-operate analyses.

Members of our team have relevant technical experience in academic, clinical, industrial and research settings, and have earned advanced degrees in biochemistry, cellular biology, chemistry, microbiology and molecular biology. We have taught courses at major universities in patent law, virology, molecular biology and genetics, and authored legal and scientific publications. In addition, we have presented topics in patent law to nationwide audiences.

Our technical and legal experience enables us to provide strategic portfolio management and counseling to help our clients achieve their goals and objectives.

We have experience drafting and prosecuting patent applications covering a variety of technologies, including:

  • biologics,
  • small molecule therapeutics,
  • diagnostic methods including genomic or proteomic markers predictive of diagnosis,
  • therapeutic response,
  • prognosis or metastases,
  • research tools including cloning vectors,
  • expression constructs,
  • fluorescent or luminescent proteins,
  • biomolecule separation and purification,
  • PCR methods,
  • transgenic plants, animals or microorganisms,
  • genetically modified proteins,
  • biomolecular assays,
  • biosensors,
  • probiotics,
  • RNA-based therapeutics, bioengineered tissues, antibiotics, stem-cell based therapeutics,
  • drug delivery,
  • treatment of diseases such as bone, skin, autoimmune, immunodeficiency and hyperproliferative diseases,
  • vaccines,
  • adjuvants,
  • monoclonal antibodies,
  • biofuels,
  • bioremediation,
  • gene therapy,
  • agricultural methods,
  • plant varietals,
  • protein therapeutics,
  • cell and tissue cultures,
  • food and beverage manufacture and products, and
  • bioprocess engineering.

In addition to biotechnology patents, our attorneys in the Group handle matters involving other aspects of intellectual property. For more information regarding specific areas, please visit the Patents, Trademarks and Copyrights, Client Counseling, Transactions and Litigation pages.